Literature DB >> 380492

Effects of dopamine agonists and antagonists in Tourette's disease.

M Feinberg, B J Carroll.   

Abstract

The actions of haloperidol, dextroamphetamine sulfate, levamfetamine succinate, apomorphine, and piribedil were studied in two patients with Giles de la Tourette's disease in an attempt to clarify the catecholamine mechanisms involved in this condition. Both dextroamphetamine and levamfetamine increased the severity of the symptoms; dextroamphetamine was more potent. Haloperidol controlled the symptoms and also antagonized the effect of dextroamphetamine. Apomorphine injections reduced the severity of symptoms, even in the presence of dextroamphetamine. We conclude that dopamine rather than norepinephrine is the principal catecholamine responsible for the symptoms. The effect of apomorphine may be understood through its action on postulated presynaptic inhibitory dopamine receptors, or other presynaptic mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 380492     DOI: 10.1001/archpsyc.1979.01780090065007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  17 in total

1.  Carbidopa-levodopa-induced recrudescence of premorbid tic disorder in remission.

Authors:  Tariq Latif; Raphael J Leo; Yogesh D Bakhai
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 2.  Do autoreceptors mediate dopamine agonist--induced yawning and suppression of exploration? A critical review.

Authors:  L Ståhle
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Paradoxical worsening of tics with haloperidol.

Authors:  Kamal Nath; Arnab Bhattacharya; Susmita Hazarika; Debjit Roy; Samir Kumar Praharaj
Journal:  Ther Adv Psychopharmacol       Date:  2015-10

Review 4.  Gilles de la Tourette syndrome: a review.

Authors:  M Lawden
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

5.  Tourette's syndrome in a black woman with associated triple X and 9p mosaicism.

Authors:  D N Singh; G L Howe; H W Jordan; S Hara
Journal:  J Natl Med Assoc       Date:  1982-07       Impact factor: 1.798

Review 6.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

Review 7.  A controlled study of Tourette syndrome. VII. Summary: a common genetic disorder causing disinhibition of the limbic system.

Authors:  D E Comings
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

8.  Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test.

Authors:  D E Grice; J F Leckman; D L Pauls; R Kurlan; K K Kidd; A J Pakstis; F M Chang; J D Buxbaum; D J Cohen; J Gelernter
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

Review 9.  Tourette's syndrome: are stimulants safe?

Authors:  Roger Kurlan
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

10.  Observations and ratings of tics in school settings.

Authors:  E E Nolan; K D Gadow; J Sverd
Journal:  J Abnorm Child Psychol       Date:  1994-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.